Literature DB >> 7216431

Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.

J E Oakes, W B Davis, J A Taylor, W A Weppner.   

Abstract

Passively acquired immunity to herpes simplex virus (HSV) was studied in antithymocyte serum (ATS)-treated mice and athymic nude mice to determine whether immunocompetent lymphocytes contribute to the protection observed after transfer of HSV-specific antibody to infected animals. Mice were given three intraperitoneal injections of 0.1 ml of ATS at 24-h intervals. This treatment reduced concanavalin A and lipopolysaccharide stimulation of lymphocytes harvested from these animals by 90% when compared with the stimulation of lymphocytes harvested from untreated animals. It was found that intraperitoneal injection of 0.5 ml of specific antibody 8 h after corneal HSV type 1 infection or subcutaneous HSV type 2 infection did not protect ATS-treated animals from virus infection. Specific antibody passively transferred to ATS-treated animals 8 and 120 h postinfection also failed to protect lymphocyte-depleted animals from HSV. However, ATS-treated animals were protected from HSV infection by passively acquired antibody when lymphocytes harvested from these animals regained 80% of their ability to be stimulated with concanavalin A and lipopolysaccharide. It was also found that specific antibody conferred protection to nude mice infected with HSV only if they were first reconstituted with syngeneic thymus cells 48 h before infection. The results suggest that both antiviral antibody and thymus-derived lymphocytes contribute to the recovery of HSV-infected hosts after passive immunization.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216431      PMCID: PMC551174          DOI: 10.1128/iai.29.2.642-649.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Selective induction of DNA synthesis in T and B lymphocytes.

Authors:  J Andersson; G Möller; O Sjöberg
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

2.  Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.

Authors:  F A Ennis
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

3.  Observations on the immunobiology of 'nude' mice.

Authors:  E M Pantelouris
Journal:  Immunology       Date:  1971-02       Impact factor: 7.397

4.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

5.  Immune responses in congenitally thymus-less mice. I. Absence of response to oxazolone.

Authors:  H Pritchard; H S Micklem
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

6.  Inhibition or enhancement of immunological injury of virus-infected cells.

Authors:  A M Brier; C Wohlenberg; J Rosenthal; M Mage; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

7.  Effect of antilymphocyte serum on macrophage activity.

Authors:  M J Chare; J L Boak
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

8.  Antibody response in genetically thymus-less nude mice injected with normal thymus cells.

Authors:  B Kindred
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

9.  Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction.

Authors:  J G Stevens; M L Cook
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  20 in total

1.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  Stress, loneliness, and changes in herpesvirus latency.

Authors:  R Glaser; J K Kiecolt-Glaser; C E Speicher; J E Holliday
Journal:  J Behav Med       Date:  1985-09

3.  Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.

Authors:  J E Oakes; R N Lausch
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.

Authors:  K E Schneweis; J Gruber; J Hilfenhaus; A Möslein; M Kayser; M H Wolff
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

5.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.

Authors:  N Balachandran; S Bacchetti; W E Rawls
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

8.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

Authors:  M R McDermott; J R Smiley; P Leslie; J Brais; H E Rudzroga; J Bienenstock
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

9.  Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.

Authors:  H F Staats; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.

Authors:  J T Rector; R N Lausch; J E Oakes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.